VF
LGND icon

Vista Finance’s Ligand Pharmaceuticals LGND Stock Holding History

Vista Finance’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+882
New +$208K 0.16% 45

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Vista Finance's LGND Position: Q2 2026 in Review

Vista Finance opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 882 shares worth $279K. The stake represents 0.16% of the portfolio and ranks #45 among its holdings.

123 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Vista Finance held 882 shares of Ligand Pharmaceuticals worth $279K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Vista Finance position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.16% of Vista Finance's portfolio in Q2 2026, its #45 holding.
  • 123 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Vista Finance's 13F filing for Q2 2026, filed 16 Jul 2026.